Treatment of adult Langerhans cell histiocytosis with etoposide
- 31 July 1992
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 27 (1) , 61-64
- https://doi.org/10.1016/0190-9622(92)70157-b
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Unusual Skin Tumors in Langerhans' Cell HistiocytosisArchives of Dermatology, 1990
- A flow cytometric study of Langerhans cell histiocytosisBritish Journal of Dermatology, 1989
- Etoposide (VP16) in the treatment of multisystem langerhans cell histiocytosis (histiocytosis X)Medical and Pediatric Oncology, 1989
- Drug monitoring of etoposide (VP16-213)Cancer Chemotherapy and Pharmacology, 1987
- Histiocytosis X presenting as intertrigo and responding to topical nitrogen mustardClinical and Experimental Dermatology, 1986
- Histiocytosis X--current controversies.Archives of Disease in Childhood, 1985
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Pharmacokinetics of VP16-213 given by different administration methodsCancer Chemotherapy and Pharmacology, 1982
- Epidermal Langerhans cells are derived from cells originating in bone marrowNature, 1979
- Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.The Journal of cell biology, 1975